Amino acid levels in some brain areas of inducible nitric oxide synthase knock out mouse (iNOS-/-) before and after pentylenetetrazole kindling

Pharmacology Biochemistry and Behavior

Volumn 85, Issue 4, 2006, Pages 804-812

  De Luca, Grazia ^a   Di Giorgio, Rosa Maria ^a   Macaione, Salvatore ^a   Calpona, Pina Rita ^a   Di Paola, Eugenio Donato ^b   Costa, Nicola ^b,c   Cuzzocrea, Salvatore ^a   Citraro, Rita ^b   Russo, Emilio ^b   De Sarro, Giovambattista ^b  

^a UNIVERSITY OF MESSINA   (Italy)

^b School of Medicine   (Italy)

^c University of Catanzaro Magna Graecia   (Italy)

Author keywords

Epilepsy; Inducible nitric oxide knock out mice; Neuroactive amino acids; Pentylenetetrazole kindling; Seizures

Indexed keywords

4 AMINOBUTYRIC ACID; AMINO ACID; BENZODIAZEPINE DERIVATIVE; GLYCINE; INDUCIBLE NITRIC OXIDE SYNTHASE; NEUROTRANSMITTER; NITRIC OXIDE; PENTETRAZOLE; TAURINE;

AMINO ACID ANALYSIS; AMINO ACID BRAIN LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CORTEX; BRAIN REGION; BRAIN STEM; CEREBELLUM; CONTROLLED STUDY; CONVULSION; CORRELATION ANALYSIS; DIENCEPHALON; EPILEPSY; EPILEPTOGENESIS; EXPERIMENTAL MODEL; HIPPOCAMPUS; KINDLING; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE;

AMINO ACIDS; ANIMALS; BRAIN; CONVULSANTS; GABA ANTAGONISTS; GAMMA-AMINOBUTYRIC ACID; KINDLING, NEUROLOGIC; MICE; MICE, KNOCKOUT; NITRIC OXIDE SYNTHASE TYPE II; PENTYLENETETRAZOLE; RECEPTORS, GABA-A; SEIZURES; TAURINE;

MUS;

EID: 33846542619     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2006.11.016     Document Type: Article

References (66)

1. al-Ghoul W.M., Meeker R.B., and Greenwood R.S. Kindling induces a long-lasting increase in brain nitric oxide synthase activity. NeuroReport 6 (1995) 457-460
2. Bradford H.F., and Peterson D.W. Current views of the pathobiochemistry of epilepsy. Mol Aspects Med 9 (1987) 119-172
3. Bredt D.S., and Snyder S.H. Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc Natl Acad Sci U S A 86 (1989) 9030-9033
4. Bredt D.S., and Snyder S.H. Nitric oxide: a physiologic messenger molecule. Annu Rev Biochem 63 (1994) 175-195
5. Brevard M.E., Kulkarni P., King J.A., and Ferris C.F. Imaging the neural substrates involved in the genesis of pentylenetetrazol-induced seizures. Epilepsia 47 (2006) 745-754
6. Buchhalter J.R. Animal models of inherited epilepsy. Epilepsia 34 (1993) S31-S41
7. Burgess D.L., and Noebels J.L. Single gene defects in mice: the role of voltage dependent calcium channels in absence models. Epilepsy Res 36 (1999) 111-122
8. Cohen S.A., Meys M., and Tarwin T.L. The Pico-Tag method - a manual of advanced techniques for amino acid analysis, Rev 1. Bedford (MA)' Millipore (1989) 1-123
9. Corda M.G., Orlandi M., Lecca D., Carboni G., Frau V., and Giorgi O. Pentylenetetrazol-induced kindling in rats: effect of GABA function inhibitors. Pharmacol Biochem Behav 40 (1991) 329-333
10. Cuzzocrea S., Chatterjee P.K., Mazzon E., Dugo L., De Sarro A., Van de Loo F.A., et al. Role of induced nitric oxide in the initiation of the inflammatory response after postischemic injury. Shock 18 (2002) 169-176
11. da Silva L.F., Pereira P., and Elisabetsky E. A neuropharmacological analysis of PTZ-induced kindling in mice. Gen Pharmacol 31 (1998) 47-50
12. De Luca G., Di Giorgio R.M., Macaone S., Calpona P.R., Costantino S., Donato Di Paola E., et al. Amino acid levels in some lethargic mouse brain areas before and after pentylenetetrazole kindling. Pharmacol Biochem Behav 81 (2005) 47-53
13. De Sarro G.B., Donato Di Paola E., De Sarro A., and Vidal M.J. Role of nitric oxide in the genesis of excitatory amino acid-induced seizures from the deep prepiriform cortex. Fundam Clin Pharmacol 5 (1991) 503-511
14. De Sarro G.B., Donato Di Paola E., De Sarro A., and Vidal M.J. l-Arginine potentiates excitatory amino acid-induced seizures elicited in the deep prepiriform cortex. Eur J Pharmacol 230 (1993) 151-158
15. De Sarro G., Gareri P., Falconi U., and De Sarro A. 7-Nitroindazole potentiates the antiseizure activity of some anticonvulsants in DBA/2 mice. Eur J Pharmacol 394 (2000) 275-288
16. De Sarro G., Ferreri Ibbadu G., Marra R., Rotiroti D., Loiacono A., Donato Di Paola E., et al. Seizure susceptibility to various convulsant stimuli in dystrophin-deficient mdx mice. Neurosci Res 50 (2004) 37-44
17. De Sarro G., Russo E., Ferreri G., Bruzzese G., Flocco M.A., Donato Di Paola E., et al. Seizure susceptibility to various convulsant stimuli of knockout interleukin 6 mice. Pharmacol Biochem Behav 77 (2004) 761-766
18. de Vasconcelos A.P., Gizard F., Marescaux C., and Nehlig A. Role of nitric oxide in pentylenetetrazol-induced seizures: age-dependent effects in the immature rat. Epilepsia 41 (2000) 363-371
19. Desvignes C., Bert L., Vinet L., Denory L., Renaud B., and Lambas-Senas L. Evidence that neuronal oxide synthase inhibitor 7-nitroindazole inhibits monoamine oxidase in rat: in vivo effects on extracellular striatal dopamine and 3,4-dihydrophenilacetic acid. Neurosci Lett 264 (1999) 5-8
20. Ekonomou A., and Angelatou F. Upregulation of NMDA receptors in hippocampus and cortex in the pentylenetetrazol-induced "kindling" model of epilepsy. Neurochem Res 24 (1999) 1515-1522
21. Ekonomou A., Smith A.L., and Angelatou F. Changes in AMPA receptor binding and subunit messenger RNA expression in hippocampus and cortex in the pentylenetetrazole-induced kindling model of epilepsy. Brain Res Mol Brain Res 95 (2001) 27-35
22. El-Abhar H.S., and El Gawad H.M. Modulation of cortical nitric oxide synthase, glutamate, and redox state by nifedipine and taurine in PTZ-kindled mice. Epilepsia 44 (2003) 276-281
23. Eloquayli H., Dahl C.B., Gotestam K.G., Unsgard G., Hadidi H., and Sonnewald U. Pentylenetetrazole decreases metabolic glutamate turnover in rat brain. J Neurochem 85 (2003) 1200-1207
24. Engstrom F.L., and Woodbury D.M. Seizure susceptibility in DBA and C57 mice: the effects of various convulsants. Epilepsia 29 (1988) 389-395
25. Haberny K.A., Pou S., and Eccles C.U. Potentiation of quinolinate-induced hippocampal lesions by inhibition of NO synthesis. Neurosci Lett 146 (1992) 187-190
26. Han D., Yamada K., Senzaki K., Xiong H., Nawa H., and Nabeshima T. Involvement of nitric oxide in pentylenetetrazole-induced kindling in rats. J Neurochem 74 (2000) 792-798
27. Hara S., Kuriiwa F., Iwata N., Mukai T., Kano S., and Endo T. Distinct effects of N-ω-nitro-l-arginine on seizures induced by several drugs in mice. Pharmacol Biochem Behav 53 (1996) 673-677
28. Heneka M.T., and Feinstein D.L. Expression and function of inducible nitric oxide synthase in neurons. J Neuroimmunol 114 (2001) 8-18
29. Kaura S., Bradford H.F., Young A.M., Croucher M.J., and Hughes P.D. Effect of amygdaloid kindling on the content and release of amino acids from the amygdaloid complex: in vivo and in vitro studies. J Neurochem 65 (1995) 1240-1249
30. Lasley S.M. Roles of neurotransmitter amino acids in seizure severity and experience in the genetically epilepsy-prone rat. Brain Res 560 (1991) 63-70
31. Lasley S.M., and Yan Q.S. Diminished potassium-stimulated GABA release in vivo in genetically epilepsy-prone rats. Neurosci Lett 175 (1994) 145-148
32. Leech C.K., and McIntyre D.C. Kindling rates in inbred mice: an analog to learning?. Behav Biol 16 (1976) 439-452
33. Libri V., Santarelli R., Nisticò S., and Azzena G. Inhibition of nitric oxide synthase prevents magnesium-free-induced epileptiform activity in guinea-pig piriform cortex neurones in vitro. Naunyn-Schmiedeberg's. Arch Pharmacol 355 (1997) 452-456
34. Lipton S.A., Singel D.J., and Stamler J.S. Nitric oxide in the central nervous system. Prog Brain Res 103 (1994) 359-364
35. Litchfield J.T., and Wilcoxon F. A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 96 (1949) 99-113
36. Lowenstein C.J., Dinerman J.L., and Snyder S.H. Nitric oxide: a physiologic messenger. Ann Intern Med 120 (1994) 227-237
37. Maggio R., Fumagalli F., Donati E., Barbier P., Racagni G., Corsini G.U., et al. Inhibition of nitric oxide synthase dramatically potentiates seizures induced by kainic acid and pilocarpine in rats. Brain Res 679 (1995) 184-187
38. Mashimo H., and Goyal R.K. Lessons from genetically engineered animal models. IV. Nitric oxide synthase gene knockout mice. Am J Physiol 277 (1999) 745-750
39. McNamara J.O., Bonhaus D.W., Crain B.J., Gellman R.L., and Shin C. Biochemical and pharmacological studies of neurotransmitters in the kindling model. In: Jobe P.C., and Laird II H.E. (Eds). Neurotransmitters and epilepsy (1989), Clifton (NJ)' Humana Press 115-160
40. Meldrum B.S., Akbar M.T., and Chapman A.G. Glutamate receptors and transporters in genetic and acquired models of epilepsy. Epilepsy Res 36 (1999) 189-204
41. Mollace V., Bagetta G., and Nistico G. Evidence that l-arginine possesses proconvulsant effects mediated through nitric oxide. NeuroReport 2 (1991) 269-272
42. Moncada S., Palmer R.M.J., and Higgs E.A. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 43 (1991) 109-142
43. Moncada C., Lekieffre D., Arvin B., and Meldrum B. Effect of NO synthase inhibition of NMDA- and ischaemia-induced hippocampal lesions. NeuroReport 3 (1992) 530-532
44. Mülsch A., Busse R., Mordvintcev P.I., Vanin A.F., Nielsen E.O., Scheel-Krüger J., et al. Nitric oxide promotes seizure activity in kainate-treated rats. NeuroReport 5 (1994) 2325-2328
45. Musumeci S.A., Bosco P., Calabrese G., Bakker C., De Sarro G.B., Elia M., et al. Audiogenic seizures susceptibility in transgenic mice with fragile X syndrome. Epilepsia 41 (2000) 19-23
46. Oishi R., and Suenaga N. The role of the locus coeruleus in regulation of seizure susceptibility in rats. Jpn J Pharmacol 32 (1982) 1075-1081
47. Osonoe K., Mori N., Suzuki K., and Osonoe M. Antiepileptic effects of inhibitors of nitric oxide synthase examined in pentylenetetrazol-induced seizures in rats. Brain Res 663 (1994) 338-340
48. Owens D.F., and Kriegstein A.R. Is there more to GABA than synaptic inhibition?. Nat Rev Neurosci 3 (2002) 715-727
49. Park K.K., Reuben J.S., and Soliman K.F. The role of inducible-nitric oxide in cocaine-induced kindling. Exp Biol Med (Maywood) 226 (2001) 185-190
50. Psarropoulou C., Matsokis N., Angelatou F., and Kostopoulos G. Pentylenetetrazol-induced seizures decrease gamma-aminobutyric acid-mediated recurrent inhibition and enhance adenosine-mediated depression. Epilepsia 35 (1994) 12-19
51. Rondouin G., Lerner-Natoli M., Manzoni O., Lafon-Cazal M., and Bockaert J. A nitric oxide (NO) synthase inhibitor accelerates amygdala kindling. NeuroReport 3 (1992) 805-808
52. Rondouin G., Bockaert J., and Lerner-Natoli M. l-Nitroarginine, an inhibitor of NO synthase, dramatically worsens limbic epilepsy in rats. NeuroReport 4 (1993) 1187-1190
53. Rundfeldt C., Koch R., Richter A., Mevissen M., Gerecke U., and Löscher W. Dose-dependent anticonvulsant and proconvulsant effects of nitric oxide synthase inhibitors on seizure threshold in a cortical stimulation model in rats. Eur J Pharmacol 274 (1995) 73-81
54. Russo E., Constanti A., Ferreri G., Citraro R., and De Sarro G. Nifedipine affects the anticonvulsant activity of topiramate in various animal models of epilepsy. Neuropharmacology 46 (2004) 865-878
55. Samdani A.F., Dawson T.M., and Dawson V.L. Nitric oxide synthase in models of focal ischemia. Stroke 28 (1997) 1283-1288
56. SAS Institute Inc. SAS/STAT guide for personal computers, version. 6 edition (1987), Cary (NC)' SAS Institute Inc.
57. 3H-d-aspartate release from hippocampal tissue during the development of pentylenetetrazole kindling in rats. Pharmacol Biochem Behav 62 (1999) 349-352
58. Silva M.T., Rose S., Hindmarsh J.G., Aislaitner G., Gorrod J.W., Moore P.K., et al. Increased striatal dopamine efflux in vivo following inhibition of cerebral nitric oxide synthase by the novel monosodium salt of 7-nitroindazole. Br J Pharmacol 114 (1995) 257-258
59. Smith R.P., Louis C.A., Kruszyna R., and Kruszyna H. Acute neurotoxicity of sodium azide and nitric oxide. Fundam Appl Toxicol 17 (1991) 120-127
60. Smith S.E., Man C.M., Yip P.K., Tang E., Chapman A.G., and Meldrum B.S. The nitric oxide synthase product, l-citrulline and the nitric oxide donor, SIN-1 are convulsant, while l-arginine is anticonvulsant in rodents with inbred reflex epilepsy. Br J Pharmacol 119 (1996) 165-173
61. Swinyard E.A., and Woodhead J.M. Experimental detection, quantification and evaluation of anticonvulsants. In: Woodbury D.M., Penry J.K., and Pippinger C.E. (Eds). Antipileptic drugs (1982), New York' Raven Press 111-126
62. Szabó C. Physiological and pathophysiological roles of nitric oxide in the central nervous system. Brain Res Bull 41 (1996) 131-141
63. Theard M.A., Baughman V.L., Wang Q., Pellegrino D.A., and Albrecht R.F. The role of nitric oxide in modulating brain activity and blood flow during seizure. NeuroReport 6 (1995) 921-924
64. Tutka P., Klonowski P., Dzieciuch J., Kleinrock Z., and Czuczwar S.J. NG-nitro-l-arginine differentially affects glutamate- or kainate-induced seizures. NeuroReport 7 (1996) 1605-1608
65. Tutka P., Mlynarczyk M., Zolkowska D., Kleinrok Z., Wielosz M., and Czuczwar S.J. Nitric oxide and convulsions in 4-aminopyridine-treated mice. Eur J Pharmacol 437 (2002) 47-53
66. Urbanska E.M., Drelewska E., Borowicz K.K., Blaszczak P., Kleinrok Z., and Czuczwar S.J. NG-nitro-l-arginine and seizure susceptibility in four seizure models in mice. J Neural Transm 103 (1996) 1145-1152